| Realtime | Geld | Brief | Zeit |
|---|---|---|---|
| 2,480 | 2,560 | 21.12. |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15.10. | Avant Brands Inc (2): Avant omits P&L from Q3 NR, talks adj. net income | ||
| 15.10. | Avant Brands reports Q3 results | ||
| 15.10. | Avant Brands Inc.: Avant Brands Announces Results for Q3 2024 | Record Gross and Net Revenue: Generated $9.6 million Gross Revenue and $8.5 million Net Revenue in Q3 2024, establishing new company records.Record Export Wholesale Revenue1: Generated $5.1 million... ► Artikel lesen | |
| 23.09. | Avant Brands Inc (2): Avant Brands signs BLK MKT licensing deal for Australia | ||
| 23.09. | Avant Brands Inc.: Avant Brands Expands Global Footprint with BLK MKT Launch in Australia | KELOWNA, BC and MELBOURNE, AUSTRALIA / ACCESSWIRE / September 23, 2024 / Avant Brands Inc. (TSX:AVNT)(OTCQX:AVTBF)(FRA:1BU0) ("Avant" or the "Company"), a leading Canadian producer of award-winning... ► Artikel lesen |
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | Sonoma Pharmaceuticals, Inc. - S-8, Securities to be offered to employees in employee benefit plans | ||
| Mi | SNOA-Aktie erreicht 52-Wochen-Tief bei 2,44 US-Dollar | ||
| 06.12. | SNOA Stock Hits 52-Week Low at $2.47 Amid Market Challenges | ||
| 06.12. | SNOA-Aktie erreicht 52-Wochen-Tief bei 2,47 US-Dollar | ||
| 05.12. | Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Successfully Transitions First Products to New EU MDR Requirements for Class IIb Medical Devices | BOULDER, CO / ACCESSWIRE / December 5, 2024 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen |
| Unternehmen / Aktien | Kurs | % |
|---|---|---|
| AVANT BRANDS INC | 0,314 | -5,99 % |
| SONOMA PHARMACEUTICALS INC | 2,520 | 0,00 % |
